Patients with ST-Elevation Myocardial Infarction (STEMI) research hub

An exploratory, randomized, double-blind, multicentre, placebo-controlled study of RTP-026 to assess safety, tolerability, and efficacy in patients with ST-Elevation Myocardial Infarction (STEMI)

This study looks at a new medicine called RTP-026 for adults who have had a severe heart attack. Researchers want to see if it helps protect heart muscle after an emergency procedure to clear blocked arteries, and whether it is safe and well tolerated.